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Abstract
Molecular Epidemiology was originally conceived as a preventive approach, providing a valuable tool for
investigating risk factors for cancer in vulnerable populations. Biomarkers can be used as early indicators of risk for
preventative purposes and risk assessment. The present contribution mainly refers to in utero exposures to
carcinogens, since humans are especially vulnerable during fetal development. Environmental exposures in utero
can increase risks for both childhood and adult cancers; their interactions with genetic and nutritional susceptibility
factors may further increase risk. Thus, the early developmental period represents an important window for cancer
prevention.
Introduction
Lorenzo Tomatis was an internationally recognized pio-
neer and leader in cancer prevention. The following
remarks are made in honor of Lorenzo and his lifelong
work. Molecular Epidemiology was conceived as a pre-
ventive approach, providing a valuable tool for investi-
gating risk factors for cancer in vulnerable populations.
Biomarkers can be used as early indicators of risk for
preventative purposes and risk assessment. Humans are
especially vulnerable during fetal development. Environ-
mental exposures in utero can increase risks for both
childhood and adult cancers; their interactions with
genetic and nutritional susceptibility factors may further
increase risk. Thus, the early developmental period
represents an important window for cancer prevention.
Background on fetal susceptibility
The fetus is generally at greater risk than the adult from
toxic and carcinogenic environmental chemicals and
other agents. A number of factors are involved: the high
rates of absorption and retention of chemicals by the
fetus, inability of the fetal liver to metabolize and detox-
ify toxins efficiently, the immaturity of fetal mechanisms
of DNA repair and immune response, and the high rate
of cell proliferation. In addition to directly damaging
fetal cells and molecular/genetic targets, environmental
chemicals can interfere with fetal development by dis-
rupting the growth of the placenta and affecting the
transplacental transfer of nutrients to the fetus. Thus,
there is an increased likelihood that exposure to an
environmental toxicant during the fetal period will
result in procarcinogenic damage in the form of DNA
adducts and mutation as well as epigenetic changes [1].
Such procarcinogenic damage acquired during the fetal
period will likely persist through many more cell divi-
sions than those acquired later in life. There is therefore,
a greater opportunity for cancer and other chronic dis-
eases to develop when the causative exposure is experi-
enced in utero.
The importance of the fetal period is underscored by
the growing number of environmental exposures that
are known or suspected of increasing risk of childhood
and adult cancer when the exposure occurs during the
fetal period. These include air pollutants, such as poly-
cyclic aromatic hydrocarbons (PAHs), tobacco smoke,
pesticides, solvents, and radiation [2-7]. Fetal exposures
to endocrine disruptors have also been linked to diverse
health effects in animal studies (and to a limited extent
in humans), including cancers, immune disorders, and
obesity [8]. Thus, the fetal period represents an
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important opportunity for the prevention of cancer and
other diseases.
Results from recent molecular epidemiologic
studies
Our studies at the Center for Children’s Environmental
Health (CCCEH) relating various biologic markers to air
pollutant exposures have highlighted the susceptibility
of the fetus. In the New York City -based “Mothers and
Newborns Cohort Study”, pregnant mothers wore perso-
nal air monitors to measure their exposure to PAHs
during pregnancy [9]. PAHs are widespread carcinogens,
resulting from combustion of fossil fuels and other
organic material. PAH-DNA adducts have been asso-
ciated with cancer, both experimentally and in humans.
The level of prenatal maternal urinary PAH metabolites
has been measured as well as PAH-DNA adducts in
cord and maternal blood. Although the estimated dose
of PAH to the fetus is about 10 times lower than to the
mother, maternal and cord white blood cells had equiva-
lent levels of PAH-DNA adducts [10]. This finding sup-
ports the increased susceptibility of the fetus to
procarcinogenic DNA damage by these common envir-
onmental carcinogens [11].
In the same cohort study, lymphocytes were examined
in cord blood using whole-chromosome painting and
fluorescent in situ hybridization (FISH). High prenatal
PAH exposure was associated with a higher frequency
of stable chromosomal aberrations in cord blood
[12,13]. These results showed a link between transpla-
cental exposure to PAHs and genetic damage which
may potentially increase risk of cancer. We are currently
investigating the relationship between exposure, chro-
mosomal aberrations and the TEL-AML1 preleukemic
alteration.
My colleagues and I are evaluating the effects of pre-
natal exposures to PAHs and other environmental toxi-
cants on epigenetic programming, specifically altered
DNA methylation. DNA methylation is a covalent modi-
fication at cytosine residues of DNA, often occurring in
promoter regions and inhibiting transcription [14]. DNA
methylation is believed to play a role in tumor forma-
tion. One example is the hypermethylation of tumor
suppressor genes leading to a loss of expression [15]
and the global hypomethylation seen in lung cancer
[16]. PAHs have been shown to alter DNA methylation
patterns in various types of tumor cells. The fetus is
particularly susceptible to exposures that can alter epi-
genetic markers because these patterns, which are gen-
erally heritable through successive cell divisions, are
largely cleared and then re-established during early fetal
development [17].
In our NYC cohort study, we have found that global
DNA methylation levels in cord blood white blood cells
decreased with increasing prenatal PAH exposure
[Herbstman et al. 2010 in prep.]. Interestingly, we also
found that global DNA methylation levels in cord blood
were positively correlated with levels of PAH-DNA
adducts in cord blood; thus adducts do not appear to
mediate or modify the inverse association between PAH
exposure and DNA methylation levels. These results
indicate that the fetal epigenome is vulnerable to PAH
exposure and that epigenetic dysregulation in the devel-
oping fetus due to PAH exposure does not directly
involve PAH-DNA adduct formation. The results are
consistent with experimental evidence that PAH-DNA
adducts form preferentially at methylated DNA sites and
that DNA methylation may make DNA more reactive
and, therefore, more vulnerable to genetic damage by
PAHs and other chemicals [18].
Regarding persistence of epigenetic changes due to
prenatal exposure, comparison of methylation levels in
cord blood and blood collected at age 3 from the same
children showed that methylation levels did not vary sig-
nificantly over time. This suggests that PAH-related epi-
genetic perturbations are relatively stable over this
period and could contribute to a wide range of health
effects throughout childhood and possibly later in life.
One of the disadvantages of the studies described
above is that we measured overall DNA methylation
levels, not the methylation status of specific genes. We
are now examining the effects of prenatal PAH exposure
on DNA methylation of specific genes. In a pilot study,
our colleagues at the University of Cincinnati and we
identified genes with differential methylation levels in
cord white blood cells between children with low prena-
tal PAH exposure and high prenatal PAH exposure [19].
We are currently using high throughput genome wide
arrays in our birth cohorts in NYC and Poland to iden-
tify additional genes whose methylation patterns are vul-
nerable to disease-inducing perturbation by PAHs.
Conclusion
Our studies provide molecular and genetic evidence of
widespread exposure to PAHs, increased fetal suscept-
ibility, and links between in utero exposure and biomar-
kers of potentially increased cancer risk, such as adducts
and chromosomal aberrations. We have also found that
prenatal PAH exposure affects epigenetic patterning by
altering DNA methylation. Epigenetic alterations have
been shown to play a role in cancer, and have also been
found to be associated with a wide range of other dis-
eases. Thus, increased fetal susceptibility to environmen-
tal contaminants can contribute to molecular alterations,
quantifiable as biomarkers, which potentially increased
risk of cancer and multiple diseases that may present
across the life course. Measuring biomarkers associated
with fetal exposure can therefore inform risk assessment
Perera Environmental Health 2011, 10(Suppl 1):S5
http://www.ehjournal.net/content/10/S1/S5
Page 2 of 3
and early intervention programs aimed at preventing
cancer and other environmentally-related diseases.
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